InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+6.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by SHOVLIN ROBERT J., Président des Services Cliniques. Officer active across 1 company, notably Neogenomics INC. Aggregated, 2 reports have been recorded. History available since 25 May 2021. The latest transaction was disclosed on 25 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
96,167 shares@ US$8.030.059% mcap50.0% of flowCommon StockSEC:0001077183-21-000134:0
96,167 shares@ US$8.0350.0% of flowCommon StockSEC:0001077183-21-000134
2 of 2 declarations
About SHOVLIN ROBERT J.
Robert J. Shovlin is the President of Clinical Services at Neogenomics Inc. He leads the company's clinical operations, ensuring efficiency and quality of services. His expertise in biotechnology is crucial for developing innovative health solutions.
